ProText Mobility, Inc. (TXTM)
OTCMKTS · Delayed Price · Currency is USD
0.0048
-0.0001 (-2.04%)
Feb 12, 2026, 2:19 PM EST
ProText Mobility Market Cap
ProText Mobility has a market cap or net worth of $43.08 million as of February 12, 2026. Its market cap has increased by 444.44% in one year.
Market Cap
43.08M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 3, 2017, ProText Mobility's market cap has increased from 584.01K to 43.08M, an increase of 7,276.11%. That is a compound annual growth rate of 60.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 43.08M | 44.12% |
| Dec 31, 2025 | 29.89M | 240.00% |
| Dec 31, 2024 | 8.79M | -41.18% |
| Dec 29, 2023 | 14.95M | 19.00% |
| Dec 30, 2022 | 12.56M | 21.42% |
| Dec 31, 2021 | 10.34M | 276.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 43.94M |
| ZIVO Bioscience | 40.77M |
| Arch Biopartners | 39.22M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| Oncotelic Therapeutics | 28.70M |